Cyanotech Corp financial data

Symbol
CYAN on OTC
Industry
Medicinal Chemicals & Botanical Products
Location
73 4460 Queen Kaahumanu Hwy, Suite 102, Kailua Kona, HI
State of incorporation
NV
Fiscal year end
March 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 128 % -40.2%
Quick Ratio 91.9 % -46.2%
Debt-to-equity 107 % +39.6%
Return On Equity -40.2 % -56.3%
Return On Assets -19.5 % -33.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.95M shares +10.4%
Common Stock, Shares, Outstanding 6.95M shares +10.4%
Entity Public Float 3.33M USD -59.1%
Common Stock, Value, Issued 139K USD +10.3%
Weighted Average Number of Shares Outstanding, Basic 6.95M shares +10.5%
Weighted Average Number of Shares Outstanding, Diluted 6.95M shares +10.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.8M USD +10.3%
Research and Development Expense 582K USD -18.6%
Selling and Marketing Expense 5.27M USD +8.54%
General and Administrative Expense 4.46M USD -3.17%
Operating Income (Loss) -4.42M USD -19.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.09M USD -17.8%
Income Tax Expense (Benefit) 7K USD -53.3%
Net Income (Loss) Attributable to Parent -5.1M USD -17.6%
Earnings Per Share, Basic -0.76 USD/shares -10.1%
Earnings Per Share, Diluted -0.76 USD/shares -10.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 720K USD +11.1%
Accounts Receivable, after Allowance for Credit Loss, Current 2.14M USD +19.1%
Inventory, Net 6.96M USD -33.7%
Assets, Current 10.4M USD -22.2%
Property, Plant and Equipment, Net 9.78M USD -11.6%
Operating Lease, Right-of-Use Asset 4.16M USD -10.7%
Other Assets, Noncurrent 124K USD +45.9%
Assets 24.4M USD -16.1%
Accounts Payable, Current 2.31M USD +34.3%
Accrued Liabilities, Current 587K USD -28.5%
Contract with Customer, Liability, Current 278K USD +261%
Liabilities, Current 10.2M USD +13.6%
Operating Lease, Liability, Noncurrent 3.61M USD -12.9%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 13.8M USD -2.27%
Retained Earnings (Accumulated Deficit) -24.1M USD -26.8%
Stockholders' Equity Attributable to Parent 10.7M USD -29.1%
Liabilities and Equity 24.4M USD -16.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 243K USD
Net Cash Provided by (Used in) Financing Activities -183K USD -144%
Net Cash Provided by (Used in) Investing Activities -47K USD +68.7%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 6.95M shares +10.4%
Common Stock, Par or Stated Value Per Share 0.02 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 13K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 974K USD -62.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 164K USD +8.61%
Deferred Tax Assets, Valuation Allowance 4.39M USD +47%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 6.51M USD +20.5%
Operating Lease, Liability 4.15M USD -10.6%
Lessee, Operating Lease, Liability, to be Paid 5.65M USD -12.6%
Property, Plant and Equipment, Gross 37.4M USD +0.7%
Operating Lease, Liability, Current 536K USD +8.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 801K USD -1.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 794K USD +30.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.51M USD -17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 591K USD -25.6%
Deferred Tax Assets, Operating Loss Carryforwards 4.47M USD +25.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 391K USD -51.2%
Additional Paid in Capital 34.6M USD +2.09%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.56M USD -5.17%
Deferred Tax Assets, Net of Valuation Allowance 2.11M USD -12.4%
Interest Expense 669K USD +8.25%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%